We’re back again to take look at the cannabis industry’s top performers for the week ending May 18th, 2018. Out of over 200 publicly listed cannabis companies, there were some noteworthy gainers in the mix. Using our criteria of being up over 5% on the week and having market capitalizations of $30 million USD or more, this week's 4 biggest weed stock winners are:

CannaRoyalty Corp. (CSE:CRZ) (OTC:CNNRF)

CannaRoyalty is a fully integrated, active investor and operator in the legal cannabis sector. Recently, the company announced that its wholly-owned California-based distribution subsidiary, Alta Supply, generated record monthly revenue of ~US$840,000 in the month of April. Shares of CannaRoyalty performed well this week on the OTC markets. Monday morning shares opened at $3.78 USD. By Friday, they closed at $4.16 USD. This represents a gain of over 10% on the week. 

Canopy Growth Corporation (TSX:WEED) (OTC:TWMJF)

Canopy Growth Corporation is a world leading diversified cannabis company. Recently, the company announced it has applied to list its common shares on the New York Stock Exchange. Shares of Canopy Growth Corporation performed well this week on the OTC markets. Monday morning shares opened at $24.73 USD. By Friday, they closed at $28.00 USD. This represents a gain of over 13% on the week.

Golden Leaf Holdings Ltd. (CSE:GLH) (OTC:GLDFF)

Golden Leaf Holdings Ltd. is one of the largest cannabis oil and solution providers in North America. Recently, Golden Leaf announced that it has signed a letter of intent to acquire two large cannabis cultivation facilities and their associated cultivation licenses. Shares of Golden Leaf performed well this week on the OTC markets. Monday morning shares opened at $0.184 USD. By Friday, they closed at $0.195 USD. This represents a gain of over 5% on the week. 

Zynerba Pharmaceuticals Inc. (NASDAQ:ZYNE)

Zynerba Pharmaceuticals is a pharmaceutical company focused on developing and marketing synthetic cannabinoid therapeutics for transdermal delivery. Recently, Zynerba reported financial results for the first quarter ended March 31, 2018. Shares of Zynerba performed well this week on the Nasdaq. Monday morning shares opened at $9.22 USD. By Friday, they closed at $10.28 USD. This represents a gain of over 11% on the week. 

Want to learn how to invest?

Get a free 10 week email series that will teach you how to start investing.

Delivered twice a week, straight to your inbox.